(0.61±0.12)%,差异明显(P〈0.05);按照肿瘤分期,Iv期患者外周血中CD33+HLA—DR-髓源抑制性细胞水平高于I期,II期及III期,差异明显(P〈0.05);外周血中CD33+HLA—DR-髓源抑制性细胞表达水平与年龄,性别无关.结论:在肾癌患者外周血中,CD33+HLA—DR-髓源抑制性细胞表达水平与肿瘤分期,病理分型明显相关,可为...
CD33+HLA—DR-髓源抑制性细胞在肾癌患者外周血中的表达及临床意义
Results Decidua harbors CD33 / HLA- DRneg and CD33 / HLA- DR / cells which both express arginase, iNOS and IDO and a typical cytokine profile. Both subtypes potently suppress T-cell proliferation and therefore fulfill the criteria of MDSC. Conclusion We characterized a new population...
CD33(+)/HLA-DRneg and CD33(+)/HLA-DR+/- Cells: Rare Populations in the Human Decidua with Characteristics of MDSC Cd33(+)/hla-dr(neg) and cd33(+)/hla-dr(+/-) cells: rare populations in the human decidua with characteristics of mdsc. Am. J. Reprod. Immunol... ...
functionally by microscopy, FACS analysis, RT-PCR, Western blotting and in the coculture with T cells.Decidua harbors CD33+/HLA-DRneg and CD33+/HLA-DR+/− cells which both express arginase, iNOS and IDO and a typical cytokine profile. Both subtypes potently suppress T-cell proliferation and...
Blood CD33(+)HLA- DR(-) myeloid-derived suppressor cells are increased with age and a history of cancer. J Leukoc Biol. 2013;93:633-7... Chris,P,Verschoor,... - 《Journal of Leukocyte Biology》 被引量: 122发表: 2013年 Increased circulating myeloid-derived suppressor cells correlate with...
【答案】：E根据POX(+)，CD13(+)，CD33(+)可确定为粒细胞白血病。AML-M原始粒细胞免疫学表型HLA-DR和CD34均为阳性，而AML-M的细胞免疫学表型HLA-DR和CD334均为阴性。
骨髓检查原始白血病细胞85%,POX染色(+),免疫学检查CD13(+)、CD33(+)、HLA-DR(-)、CD34(-),应诊断为 A. 急性非淋巴细胞白血病M型 B. 急性非淋巴细胞白血病M型 C. 急性非淋巴细胞白血病M型 D. 急性非淋巴细胞白血病M型 E. 急性非淋巴细胞白血病M型 ...
骨髓检查原始白血病细胞85%,POX染色(+),免疫学检查CD13(+)、CD33(+)、HLA-DR(—)、CD34(—),应诊断为 A. 急性非淋巴细胞白血病M1型
符合急性早幼粒细胞白血病的免疫表型是:A.CD34+,HLA-DR+,CD33+,POX+B.CD34-,HLA-DR-,CD33+,POX+C.D34+,HLA-DR-